Biodegradable nanoparticles for intracellular delivery of antimicrobial agents

Journal of Controlled Release

Volumn 187, Issue , 2014, Pages 101-117

  Xie, Shuyu ^a   Tao, Yanfei ^a   Pan, Yuanhu ^a   Qu, Wei ^a   Cheng, Guyue ^a   Huang, Lingli ^a   Chen, Dongmei ^a   Wang, Xu ^a   Liu, Zhenli ^a   Yuan, Zonghui ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antimicrobial agents; Biodegradable nanoparticles; Internalization; Intracellular delivery; Intracellular release; Intracellular trafficking

Indexed keywords

MICROORGANISMS; NANOPARTICLES;

BIODEGRADABLE NANOPARTICLE; INTERNALIZATION; INTRACELLULAR DELIVERY; INTRACELLULAR RELEASE; INTRACELLULAR TRAFFICKING;

ANTIMICROBIAL AGENTS;

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BETA LACTAM; CHLORAMPHENICOL; MACROLIDE; NANOPARTICLE; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE; TUBERCULOSTATIC AGENT; VANCOMYCIN; DRUG CARRIER;

ARTICLE; BIOLOGICAL ACTIVITY; CELL MIGRATION; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; HYDROPHOBICITY; INTERNALIZATION; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE; SURFACE PROPERTY; ANIMAL; CHEMISTRY; HUMAN; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOLOGICAL TRANSPORT; DRUG CARRIERS; HUMANS; NANOPARTICLES;

EID: 84902132699     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.05.034     Document Type: Review

References (159)

1. E. Imbuluzqueta, C. Gamazo, J. Ariza, and M.J. Blanco-Prieto Drug delivery systems for potential treatment of intracellular bacterial infections Front. Biosci. (Landmark Ed) 15 2010 397 417
2. D.A. Portnoy, V. Auerbuch, and I.J. Glomski The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity J. Cell Biol. 158 2002 409 414 (Pubitemid 34851698)
3. A.A.H. Pinto-Alphandary, and P. Couvreur Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications Int. J. Antimicrob. Agents 13 2000 155 168
4. H.W. Lee Interactions between antimicrobial agents, phagocytic cells and bacteria Curr. Med. Chem. Anti-Infect. Agents 2 2003 73 82
5. E. Briones, C.I. Colino, and J.M. Lanao Delivery systems to increase the selectivity of antibiotics in phagocytic cells J. Control. Release 125 2008 210 227
6. A. Ranjan, N. Pothayee, M.N. Seleem, S.M. Boyle, R. Kasimanickam, J.S. Riffle, and N. Sriranganathan Nanomedicine for intracellular therapy FEMS Microbiol. Lett. 332 2012 1 9
7. T.J. de Faria, M. Roman, N.M. de Souza, R. De Vecchi, J.V. de Assis, A.L.G. dos Santos, I.H. Bechtold, N. Winter, M.J. Soares, L.P. Silva, M.V. De Almeida, and A. Bafica An isoniazid analogue promotes Mycobacterium tuberculosis-nanoparticle interactions and enhances bacterial killing by macrophages Antimicrob. Agents Chemother. 56 2012 2259 2267
8. I.A. Bakker-Woudenberg, R.M. Schiffelers, G. Storm, M.J. Becker, and L. Guo Long-circulating sterically stabilized liposomes in the treatment of infections Methods Enzymol. 391 2005 228 260 (Pubitemid 40254039)
9. R.M. Schiffelers, G. Storm, and I.A. Bakker-Woudenberg Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue Pharm. Res. 18 2001 780 787 (Pubitemid 32783513)
10. J.P. Wong, H. Yang, K.L. Blasetti, G. Schnell, J. Conley, and L.N. Schofield Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection J. Control. Release 92 2003 265 273 (Pubitemid 38366150)
11. P. Couvreur, E. Fattal, and A. Andremont Liposomes and nanoparticles in the treatment of intracellular bacterial infections Pharm. Res. 8 1991 1079 1086
12. A.M. Abraham, and A. Walubo The effect of surface charge on the disposition of liposome-encapsulated gentamicin to the rat liver, brain, lungs and kidneys after intraperitoneal administration Int. J. Antimicrob. Agents 25 2005 392 397 (Pubitemid 40558770)
13. M. Maurin, and D. Raoult Use of aminoglycosides in treatment of infections due to intracellular bacteria Antimicrob. Agents Chemother. 45 2001 2977 2986 (Pubitemid 32988817)
14. R. Schiffelers, G. Storm, and I. Bakker-Woudenberg Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies J. Antimicrob. Chemother. 48 2001 333 344 (Pubitemid 32898802)
15. P.F. Bonventre, and G. Gregoriadis Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes Antimicrob. Agents Chemother. 13 1978 1049
16. C. Dees, and R.D. Schultz The mechanism of enhanced intraphagocytic killing of bacteria by liposomes containing antibiotics Vet. Immunol. Immunopathol. 24 1990 135 146 (Pubitemid 20116017)
17. M.W. Fountain, C. Dees, and R.D. Schultz Enhanced intracellular killing of Staphylococcus aureus by canine monocytes treated with liposomes containing amikacin, gentamicin, kanamycin, and tobramycin Curr. Microbiol. 6 1981 373 376 (Pubitemid 12115430)
18. D.L. MacLeod, and J.F. Prescott The use of liposomally-entrapped gentamicin in the treatment of bovine Staphylococcus aureus mastitis Can. J. Vet. Res. 52 1988 445 450
19. M. Stevenson, A.J. Baillie, and R.M. Richards Enhanced activity of streptomycin and chloramphenicol against intracellular Escherichia coli in the J774 macrophage cell line mediated by liposome delivery Antimicrob. Agents Chemother. 24 1983 742 749 (Pubitemid 14203877)
20. P. Lutwyche, C. Cordeiro, D.J. Wiseman, M. St-Louis, M. Uh, M.J. Hope, M.S. Webb, and B.B. Finlay Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes Antimicrob. Agents Chemother. 42 1998 2511 2520 (Pubitemid 28462887)
21. M.W. Fountain, S.J. Weiss, A.G. Fountain, A. Shen, and R.P. Lenk Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides J. Infect. Dis. 152 1985 529 535 (Pubitemid 15018684)
22. C. Dees, M.W. Fountain, J.R. Taylor, and R.D. Schultz Enhanced intraphagocytic killing of Brucella abortus in bovine mononuclear cells by liposomes-containing gentamicin Vet. Immunol. Immunopathol. 8 1985 171 182 (Pubitemid 15014827)
23. A.I. Vitas, R. Diaz, and C. Gamazo Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus Antimicrob. Agents Chemother. 40 1996 146 151 (Pubitemid 26019687)
24. L.E. Bermudez, M. Wu, and L.S. Young Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin J. Infect. Dis. 156 1987 510 513 (Pubitemid 17139396)
25. L. Kesavalu, J.A. Goldstein, R.J. Debs, N. Duzgunes, and P.R. Gangadharam Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages Tubercle 71 1990 215 217 (Pubitemid 20287013)
26. D. Ashtekar, N. Duzgunes, and P.R. Gangadharam Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages J. Antimicrob. Chemother. 28 1991 615 617
27. L.E. Bermudez, A.O. Vau-Young, J.P. Lin, J. Cogger, and L.S. Young Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides J. Infect. Dis. 161 1990 1262 1268 (Pubitemid 20177892)
28. S. Majumdar, D. Flasher, D.S. Friend, P. Nassos, D. Yajko, W.K. Hadley, and N. Düzgüneş Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages Antimicrob. Agents Chemother. 36 1992 2808 2815
29. C. Cordeiro, D.J. Wiseman, P. Lutwyche, M. Uh, J.C. Evans, B.B. Finlay, and M.S. Webb Antibacterial efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella enterica serovar Typhimurium intracellular infection model Antimicrob. Agents Chemother. 44 2000 533 539 (Pubitemid 30117937)
30. E. Imbuluzqueta, S. Lemaire, C. Gamazo, E. Elizondo, N. Ventosa, J. Veciana, and M.J. Blanco-Prieto Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin J. Antimicrob. Chemother. 67 2012 2158 2164
31. A. Ranjan, N. Pothayee, M.N. Seleem, N. Sriranganathan, R. Kasimanickam, M. Makris, and J.S. Riffle In vitro trafficking and efficacy of core-shell nanostructures for treating intracellular Salmonella infections Antimicrob. Agents Chemother. 53 2009 3985 3988
32. A. Ranjan, N. Pothayee, M.N. Seleem, R.D. TylerJr, B. Brenseke, N. Sriranganathan, and R. Kasimanickam Antibacterial efficacy of core-shell nanostructures encapsulating gentamicin against an in vivo intracellular Salmonella model Int. J. Nanomedicine 4 2009 289 297
33. A. Ranjan, N. Pothayee, T.P. Vadala, M.N. Seleem, E. Restis, N. Sriranganathan, and R. Kasimanickam Efficacy of amphiphilic core-shell nanostructures encapsulating gentamicin in an in vitro Salmonella and Listeria intracellular infection model Antimicrob. Agents Chemother. 54 2010 3524 3526
34. Q. Zhang, G. Liao, D. Wei, and T. Nagai Increase in gentamicin uptake by cultured mouse peritoneal macrophages and rat hepatocytes by its binding to polybutylcyanoacrylate nanoparticles Int. J. Pharm. 164 1998 21 27 (Pubitemid 28160094)
35. C. Lecaroz, C. Gamazo, and M.J. Blanco-Prieto Nanocarriers with gentamicin to treat intracellular pathogens J. Nanosci. Nanotechnol. 6 2006 3296 3302 (Pubitemid 44580014)
36. N. Pothayee, N. Jain, T.P. Vadala, L.M. Johnson, R. Mejia-Ariza, N. Sriranganathan, R.M. Davis, and J.S. Riffle Block ionomer complexes containing cationic antibiotics to kill intracellular Brucella melitensis in vitro Polym. Adv. Technol. 23 2012 1484 1493
37. E. Yazar, A.L. Bas, Y.O. Birdane, K. Yapar, M. Elmas, and B. Tras Determination of intracellular (neutrophil and monocyte) concentrations of free and liposome encapsulated ampicillin in sheep Vet. Med. 51 2006 51 54 (Pubitemid 43345927)
38. M. Ito, E. Ishida, F. Tanabe, N. Mori, and S. Shigeta Inhibitory effect of liposome-encapsulated penicillin G on growth of Listeria monocytogenes in mouse macrophages Tohoku J. Exp. Med. 150 1986 281 286 (Pubitemid 17234981)
39. J.V. Desiderio, and S.G. Campbell Liposome-encapsulated cephalothin in the treatment of experimental murine salmonellosis J. Reticuloendothel. Soc. 34 1983 279 287 (Pubitemid 14249466)
40. J.V. Desiderio, and S.G. Campbell Intraphagocytic killing of Salmonella typhimurium by liposome-encapsulated cephalothin J. Infect. Dis. 148 1983 563 570 (Pubitemid 13012560)
41. A. Kresta, P.N. Shek, J. Odumeru, and J.M.A. Bohnen Distribution of free and liposome encapsulated cefoxitin in experimental intra abdominal sepsis in rats J. Pharm. Pharmacol. 45 1993 779 783 (Pubitemid 23272538)
42. N.M. Zaki, and M.M. Hafez Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium AAPS PharmSciTech 13 2012 411 421
43. I.A. Bakker-Woudenberg, A.F. Lokerse, and F.H. Roerdink Effect of lipid composition on activity of liposome-entrapped ampicillin against intracellular Listeria monocytogenes Antimicrob. Agents Chemother. 32 1988 1560 1564
44. G. Fontana, M. Licciardi, S. Mansueto, D. Schillaci, and G. Giammona Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake Biomaterials 22 2001 2857 2865 (Pubitemid 32739242)
45. H. Pinto-Alphandary, O. Balland, M. Laurent, A. Andremont, F. Puisieux, and P. Couvreur Intracellular visualization of ampicillin-loaded nanoparticles in peritoneal macrophages infected in vitro with Salmonella typhimurium Pharm. Res. 11 1994 38 46 (Pubitemid 24040761)
46. O. Balland, H. Pinto-Alphandary, A. Viron, E. Puvion, A. Andremont, and P. Couvreur Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H)ampicillin-loaded nanoparticles J. Antimicrob. Chemother. 37 1996 105 115 (Pubitemid 26123139)
47. I.A. Bakker-Woudenberg, A.F. Lokerse, J.C. Vink-van den Berg, F.H. Roerdink, and M.F. Michel Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages Antimicrob. Agents Chemother. 30 1986 295 300 (Pubitemid 16038766)
48. F. Forestier, P. Gerrier, C. Chaumard, A.M. Quero, P. Couvreur, and C. Labarre Effect of nanoparticle-bound ampicillin on the survival of Listeria monocytogenes in mouse peritoneal macrophages J. Antimicrob. Chemother. 30 1992 173 179
49. P. Couvreur, E. Fattal, H. Alphandary, F. Puisieux, and A. Andremont Intracellular targeting of antibiotics by means of biodegradable nanoparticles J. Control. Release 19 1992 259 267
50. O. Balland, H. Pinto-Alphandary, S. Pecquet, A. Andremont, and P. Couvreur The uptake of ampicillin-loaded nanoparticles by murine macrophages infected with Salmonella typhimurium J. Antimicrob. Chemother. 33 1994 509 522 (Pubitemid 24110867)
51. I.A. Bakker-Woudenberg, A.F. Lokerse, J.C. Vink-van den Berg, and F.H. Roerdink Liposome-encapsulated ampicillin against Listeria monocytogenes in vivo and in vitro Infection 16 Suppl. 2 1988 S165 S170
52. M. Youssef, E. Fattal, M.J. Alonso, L. Roblot-Treupel, J. Sauzieres, C. Tancrede, A. Omnes, P. Couvreur, and A. Andremont Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice Antimicrob. Agents Chemother. 32 1988 1204 1207
53. E. Fattal, M. Youssef, P. Couvreur, and A. Andremont Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles Antimicrob. Agents Chemother. 33 1989 1540 1543 (Pubitemid 19228010)
54. E. Fattal, J. Rojas, M. Youssef, P. Couvreur, and A. Andremont Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis Antimicrob. Agents Chemother. 35 1991 770 772
55. S. Maya, S. Indulekha, V. Sukhithasri, K.T. Smitha, S.V. Nair, R. Jayakumar, and R. Biswas Efficacy of tetracycline encapsulated O-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus Int. J. Biol. Macromol. 51 2012 392 399
56. M.N. Seleem, N. Jain, N. Pothayee, A. Ranjan, J.S. Riffle, and N. Sriranganathan Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline FEMS Microbiol. Lett. 294 2009 24 31
57. J.C. Anderson, and C.J. Kirby The effect of incorporation of cloxacillin in liposomes on treatment of experimental staphylococcal mastitis in mice J. Vet. Pharmacol. Ther. 9 1986 303 309
58. C.S. Easmon, and J.P. Crane Uptake of ciprofloxacin by human neutrophils J. Antimicrob. Chemother. 16 1985 67 73 (Pubitemid 15002352)
59. S. Chono, T. Tanino, T. Seki, and K. Morimoto Efficient drug delivery to alveolar macrophages and lung epithelial lining fluid following pulmonary administration of liposomal ciprofloxacin in rats with pneumonia and estimation of its antibacterial effects Drug Dev. Ind. Pharm. 34 2008 2006 1090 1096
60. S. Chono, T. Tanino, T. Seki, and K. Morimoto Efficient drug delivery to alveolar macrophages and lung epithelial lining fluid following pulmonary administration of liposomal ciprofloxacin in rats with pneumonia and estimation of its antibacterial effects Drug Dev. Ind. Pharm. 34 2008 1090 1096
61. Y.K. Oh, D.E. Nix, and R.M. Straubinger Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection Antimicrob. Agents Chemother. 39 1995 2104 2111
62. S. Chono, T. Tanino, T. Seki, and K. Morimoto Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification J. Pharm. Pharmacol. 59 2007 75 80 (Pubitemid 46133045)
63. S. Chono, T. Tanino, T. Seki, and K. Morimoto Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections J. Control. Release 127 2008 50 58
64. M. Fresta, A. Spadaro, G. Cerniglia, I.M. Ropero, G. Puglisi, and P.M. Furneri Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts Antimicrob. Agents Chemother. 39 1995 1372 1375
65. A.L. Bas, A. Simsek, M. Corlu, E. Yazar, M. Elmas, and Z.G. Degim Determination of intracellular concentrations of free and two types of liposome-encapsulated enrofloxacin in Anatolian shepherd dog monocytes J. Vet. Med. B 49 2002 289 293 (Pubitemid 34989762)
66. A.L. Bas, A. Simsek, O. Erganis, and M. Corlu Efficacies of liposome-encapsulated enrofloxacin against Staphylococcus aureus infection in Anatolian shepherd dog monocytes in vitro Dtsch. Tierarztl. Wochenschr. 112 2005 219 223 (Pubitemid 40916241)
67. A.L. Bas, M. Elmas, A. Simsek, B. Tras, E. Yazar, and H.H. Hadimli Efficacies of free and liposome-encapsulated enrofloxacin (Baytril(r)) against Staphylococcus aureus infection in Turkish shepherd dog neutrophils in vitro Rev. Med. Vet. 151 2000 415 420
68. N. Duzgunes, D. Flasher, M.V. Reddy, J. Luna-Herrera, and P.R. Gangadharam Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin Antimicrob. Agents Chemother. 40 1996 2618 2621 (Pubitemid 26367654)
69. K.O. Kisich, S. Gelperina, M.P. Higgins, S. Wilson, E. Shipulo, E. Oganesyan, and L. Heifets Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis Int. J. Pharm. 345 2007 154 162 (Pubitemid 350087550)
70. V. Akbari, D. Abedi, A. Pardakhty, and H. Sadeghi-Aliabadi Ciprofloxacin nano-niosomes for targeting intracellular infections: an in vitro evaluation J. Nanoparticle Res. 15 2013 1 14
71. D.P. Gnanadhas, M. Ben Thomas, M. Elango, A.M. Raichur, and D. Chakravortty Chitosan-dextran sulphate nanocapsule drug delivery system as an effective therapeutic against intraphagosomal pathogen Salmonella J. Antimicrob. Chemother. 68 2013 2576 2586
72. E.V. Shipulo, I.I. Lyubimov, O.O. Maksimenko, L.V. Vanchugova, E.A. Oganesyan, P.G. Sveshnikov, and S.E. GelPerina Development of a nanosomal formulation of moxifloxacin based on poly(butyl-2-cyanoacrylate) Pharm. Chem. J. 42 2008 145 149
73. C. Carbon Clinical relevance of intracellular and extracellular concentrations of macrolides Infection 23 Suppl. 1 1995 S10 S14
74. N. Mor, J. Vanderkolk, N. Mezo, and L. Heifets Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium Antimicrob. Agents Chemother. 38 1994 2738 2742 (Pubitemid 24374429)
75. I.I. Salem, and N. Düzgünes Efficacies of cyclodextrin- complexed and liposome encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages Int. J. Pharm. 250 2003 403 414 (Pubitemid 36084363)
76. K.K., Manoj K. Mishra, Mirabela Hali, Susan Wykes, Herve C. Gerard, Alan P. Hudson, Judith A. Whittum-Hudson, and Rangaramanujam M. Kannan PAMAM dendrimer-azithromycin conjugates nanodevices for the treatment of Chlamydia trachomatis infections Nanomedicine 7 2011 935 944
77. A. Bosnjakovic, M.K. Mishra, W. Ren, Y.E. Kurtoglu, T. Shi, D. Fan, and R.M. Kannan Poly(amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation Nanomedicine 7 2011 284 294
78. C.O. Onyeji, C.H. Nightingale, and M.N. Marangos Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin Infection 22 1994 338 342 (Pubitemid 24316420)
79. A. Pumerantz, K. Muppidi, S. Agnihotri, C. Guerra, V. Venketaraman, J. Wang, and G. Betageri Preparation of liposomal vancomycin and intracellular killing of methicillin-resistant Staphylococcus aureus (MRSA) Int. J. Antimicrob. Agents 37 2011 140 144
80. S.P. Chakraborty, S.K. Sahu, S.K. Mahapatra, S. Santra, M. Bal, S. Roy, and P. Pramanik Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents Nanotechnology 21 2010 105103
81. I. Salem, D.L. Flasher, and N. Duzgunes Liposome-encapsulated antibiotics Methods Enzymol. 391 2005 261 291 (Pubitemid 40254040)
82. V.I. Golyshevskaia, A.A. Selishcheva, L.P. Martynova, L.N. Lepekha, T.M. Kalashnikova, Z. Kornilova, V.V. Erokhin, and O.A. Rozenberg Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro Probl. Tuberk. Bolezn. Legk. 2006 61 64
83. C.O. Onyeji, C.H. Nightingale, D.P. Nicolau, and R. Quintiliani Activities of liposome-encapsulated azithromycin and rifabutin compared with that of clarithromycin against Mycobacterium avium-intracellulare complex in human macrophages Int. J. Antimicrob. Agents 4 1994 281 289 (Pubitemid 24334161)
84. C.O. Onyeji, C.H. Nightingale, D.P. Nicolau, and R. Quintiliani Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages Antimicrob. Agents Chemother. 38 1994 523 527 (Pubitemid 24072243)
85. C.O. Onyeji, C.H. Nightingale, P.R. Tessier, D.P. Nicolau, and L.M. Bow Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare J. Infect. Dis. 172 1995 810 816
86. K. Yanagihara Design of anti-bacterial drug and anti-mycobacterial drug for drug delivery system Curr. Pharm. Des. 8 2002 475 482 (Pubitemid 34449871)
87. M.C.B. Lira, M.P. Siqueira-Moura, H.M.L. Rolim-Santos, F.C.S. Galetti, A.R. Simioni, N.P. Santos, E.S.T. Do Egito, C.L. Silva, A.C. Tedesco, and N.S. Santos-Magalhaes In vitro uptake and antimycobacterial activity of liposomal usnic acid formulation J. Liposome Res. 19 2009 49 58
88. R. Gomez-Flores, R. Hsia, R. Tamez-Guerra, and R.T. Mehta Enhanced intramacrophage activity of resorcinomycin A against Mycobacterium avium-Mycobacterium intracellulare complex after liposome encapsulation Antimicrob. Agents Chemother. 40 1996 2545 2549 (Pubitemid 26367640)
89. Y.V. Anisimova, S.I. Gelperina, C.A. Peloquin, and L.B. Heifets Nanoparticles as antituberculosis drugs carriers: effect on activity against Mycobacterium tuberculosis in human monocyte-derived macrophages J. Nanoparticle Res. 2 2000 165 171 (Pubitemid 33230011)
90. I.N. Skidan, S.E. Gel'perina, S.E. Severin, and A.E. Guliaev Enhanced activity of rifampicin loaded with polybutyl cyanoacrylate nanoparticles in relation to intracellularly localized bacteria Antibiot. Khimioter. 48 2003 23 26
91. S.P. Vyas, M.E. Kannan, S. Jain, V. Mishra, and P. Singh Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages Int. J. Pharm. 269 2004 37 49 (Pubitemid 38035210)
92. A.A.P.V. Kumar, T. Dutta, and N.K. Jain Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers J. Drug Target. 14 2006 546 556 (Pubitemid 44592888)
93. N. Changsan, A. Nilkaeo, P. Pungrassami, and T. Srichana Monitoring safety of liposomes containing rifampicin on respiratory cell lines and in vitro efficacy against Mycobacterium bovis in alveolar macrophages J. Drug Target. 17 2009 751 762
94. M. Zaru, C. Sinico, A. De Logu, C. Caddeo, F. Lai, M.L. Manca, and A.M. Fadda Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation J. Liposome Res. 19 2009 68 76
95. M.A. Moretton, D.A. Chiappetta, F. Andrade, J. das Neves, D. Ferreira, B. Sarmento, and A. Sosnik Hydrolyzed galactomannan-modified nanoparticles and flower-like polymeric micelles for the active targeting of rifampicin to macrophages J. Biomed. Nanotechnol. 9 2013 1076 1087
96. R. Pandey, and G.K. Khuller Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis Tuberculosis 85 2005 227 234 (Pubitemid 40805619)
97. R. Pandey, S. Sharma, and G.K. Khuller Oral solid lipid nanoparticle-based antitubercular chemotherapy Tuberculosis 85 2005 415 420 (Pubitemid 41617396)
98. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896
99. U. Pleyer, J. Grammer, P. Kosmidis, and D.G. Ruckert Analysis of interactions between the corneal epithelium and liposomes: qualitative and quantitative fluorescence studies of a corneal epithelial cell line Surv. Ophthalmol. 39 1995 S3 S16
100. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 2003 329 347 (Pubitemid 36297053)
101. K.M. Kitchens, R.B. Kolhatkar, P.W. Swaan, and H. Ghandehari Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells Mol. Pharm. 5 2008 364 369 (Pubitemid 351579139)
102. G. Sahay, D.Y. Alakhova, and A.V. Kabanov Endocytosis of nanomedicines J. Control. Release 145 2010 182 195
103. R. Duncan, and S.C.W. Richardson Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges Mol. Pharm. 9 2012 2380 2402
104. C. Chavany, T. Le Doan, P. Couvreur, F. Puisieux, and C. Helene Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides Pharm. Res. 9 1992 441 449
105. J.A. Reddy, and P.S. Low Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation J. Control. Release 64 2000 27 37 (Pubitemid 30035305)
106. C. Moon, Y.M. Kwon, W.K. Lee, Y.J. Park, and V.C. Yang In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide J. Control. Release 124 2007 43 50 (Pubitemid 350103732)
107. L. Wasungu, and D. Hoekstra Cationic lipids, lipoplexes and intracellular delivery of genes J. Control. Release 116 2006 255 264 (Pubitemid 44854274)
108. O. Boussif, F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, and J.P. Behr A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. 92 1995 7297 7301
109. M. Neu, D. Fischer, and T. Kissel Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives J. Gene Med. 7 2005 992 1009 (Pubitemid 41195062)
110. J.K. Vasir, and V. Labhasetwar Biodegradable nanoparticles for cytosolic delivery of therapeutics Adv. Drug Deliv. Rev. 59 2007 718 728 (Pubitemid 47320811)
111. M.G. Qaddoumi, H. Ueda, J. Yang, J. Davda, V. Labhasetwar, and V.H. Lee The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers Pharm. Res. 21 2004 641 648 (Pubitemid 38457287)
112. J.K. Vasir, and V. Labhasetwar Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles Biomaterials 29 2008 4244 4252
113. W. Wijagkanalan, S. Kawakami, M. Takenaga, R. Igarashi, F. Yamashita, and M. Hashida Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats J. Control. Release 125 2008 121 130 (Pubitemid 350299608)
114. E. Fattal, J. Rojas, L. Roblot-Treupel, A. Andremont, and P. Couvreur Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity J. Microencapsul. 8 1991 29 36
115. J.M. Anderson, and M.S. Shive Biodegradation and biocompatibility of PLA and PLGA microspheres Adv. Drug Deliv. Rev. 28 1997 5 24 (Pubitemid 27497671)
116. V. Lenaerts, P. Couvreur, D. Christiaens-Leyh, E. Joiris, M. Roland, B. Rollman, and P. Speiser Degradation of poly(isobutyl cyanoacrylate) nanoparticles Biomaterials 5 1984 65 68
117. I.J. Fidler Targeting of immunomodulators to mononuclear phagocytes for therapy of cancer Adv. Drug Deliv. Rev. 2 1988 69 106
118. K. Muppidi, J. Wang, G. Betageri, and A.S. Pumerantz PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin Antimicrob. Agents Chemother. 55 2011 4537 4542
119. C. Chauvierre, D. Labarre, P. Couvreur, and C. Vauthier Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles Pharm. Res. 20 2003 1786 1793 (Pubitemid 37449452)
120. C. Lemarchand, R. Gref, and P. Couvreur Polysaccharide-decorated nanoparticles Eur. J. Pharm. Biopharm. 58 2004 327 341 (Pubitemid 39037239)
121. A. Vonarbourg, C. Passirani, P. Saulnier, P. Simard, J.C. Leroux, and J.P. Benoit Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake J. Biomed. Mater. Res. A 78 2006 620 628 (Pubitemid 44253547)
122. M. Larabi, V. Yardley, P.M. Loiseau, M. Appel, P. Legrand, A. Gulik, C. Bories, S.L. Croft, and G. Barratt Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B Antimicrob. Agents Chemother. 47 2003 3774 3779 (Pubitemid 37484987)
123. O. Harush-Frenkel, N. Debotton, S. Benita, and Y. Altschuler Targeting of nanoparticles to the clathrin-mediated endocytic pathway Biochem. Biophys. Res. Commun. 353 2007 26 32 (Pubitemid 44958337)
124. Y. Tabata, and Y. Ikada Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage Biomaterials 9 1988 356 362
125. T.D. Heath, N.G. Lopez, and D. Papahadjopoulos The effects of liposome size and surface charge on liposome-mediated delivery of methotrexate-gamma- aspartate to cells in vitro Biochim. Biophys. Acta 820 1985 74 84 (Pubitemid 16233425)
126. A. Raz, C. Bucana, W.E. Fogler, G. Poste, and I.J. Fidler Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages Cancer Res. 41 1981 487 494 (Pubitemid 11179386)
127. R.A. Schwendener, P.A. Lagocki, and Y.E. Rahman The effects of charge and size on the interaction of unilamellar liposomes with macrophages Biochim. Biophys. Acta 772 1984 93 101 (Pubitemid 14136820)
128. M. Roser, D. Fischer, and T. Kissel Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats Eur. J. Pharm. Biopharm. 46 1998 255 263 (Pubitemid 29057671)
129. F. Chellat, Y. Merhi, A. Moreau, and L. Yahia Therapeutic potential of nanoparticulate systems for macrophage targeting Biomaterials 26 2005 7260 7275 (Pubitemid 41133578)
130. K. Lee, K. Hong, and D. Papahadjopoulos Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density BBA - Biomembranes 1103 1992 185 197
131. A. Rigotti, S.L. Acton, and M. Krieger The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids J. Biol. Chem. 270 1995 16221 16224
132. M. Koval, K. Preiter, C. Adles, P.D. Stahl, and T.H. Steinberg Size of IgG-opsonized particles determines macrophage response during internalization Exp. Cell Res. 242 1998 265 273 (Pubitemid 28366542)
133. S. Rudt, and R.H. Müller In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. I. Effect of analytical parameters, particle size and particle concentration J. Control. Release 22 1992 263 271
134. G. Gregoriadis, and B. McCormack Targeting of drugs 6: strategies for stealth therapeutic systems G. Storm, I.A.J.M. Bakker-Woudenberg, R.M. Schiffelers, W.J.G. Oyen, D.J.A. Crommelin, F.H.M. Corstens, O.C. Boerman, Diagnostic and Therapeutic Targeting of Infections and Inflammatory Diseases Using Sterically Stabilized Liposomes 1998 Plenum Press New York 121 130
135. J. Rejman, V. Oberle, I.S. Zuhorn, and D. Hoekstra Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis Biochem. J. 377 2004 159 169 (Pubitemid 38114443)
136. S.K. Lai, K. Hida, S.T. Man, C. Chen, C. Machamer, T.A. Schroer, and J. Hanes Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, nondegradative pathway Biomaterials 28 2007 2876 2884 (Pubitemid 46482662)
137. M.P. Desai, V. Labhasetwar, E. Walter, R.J. Levy, and G.L. Amidon The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent Pharm. Res. 14 1997 1568 1573 (Pubitemid 28009208)
138. Z.R. Cui, C.H. Hsu, and R.J. Mumper Physical characterization and macrophage cell uptake of mannan-coated nanoparticles Drug Dev. Ind. Pharm. 29 2003 689 700 (Pubitemid 36835162)
139. R.Y. Pelgrift, and A.J. Friedman Nanotechnology as a therapeutic tool to combat microbial resistance Adv. Drug Deliv. Rev. 65 2013 1803 1815
140. J.C. Krauss, H. Poo, W. Xue, L. Mayo-Bond, R.F. Todd, and H.R. Petty Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3 J. Immunol. 153 1994 1769
141. Z. Chroneos, and V.L. Shepherd Differential regulation of the mannose and SP-A receptors on macrophages Am. J. Physiol. 269 1995 L721 L726
142. P. Camner, M. Lundborg, L. Lastbom, P. Gerde, N. Gross, and C. Jarstrand Experimental and calculated parameters on particle phagocytosis by alveolar macrophages J. Appl. Physiol. 92 2002 2608 2616 (Pubitemid 34666391)
143. M. Rajaonarivony, C. Vauthier, G. Couarraze, F. Puisieux, and P. Couvreur Development of a new drug carrier made from alginate J. Pharm. Sci. 82 1993 912 917 (Pubitemid 23317253)
144. V.C. Mosqueira, P. Legrand, A. Gulik, O. Bourdon, R. Gref, D. Labarre, and G. Barratt Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules Biomaterials 22 2001 2967 2979 (Pubitemid 32768704)
145. D. Pornpattananangkul, L. Zhang, S. Olson, S. Aryal, M. Obonyo, K. Vecchio, and C.M. Huang Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection J. Am. Chem. Soc. 133 2011 4132 4139
146. A.F. Radovic-Moreno, T.K. Lu, V.A. Puscasu, C.J. Yoon, R. Langer, and O.C. Farokhzad Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics ACS Nano 6 2012 4279 4287
147. M.H. Xiong, Y. Bao, X.Z. Yang, Y.C. Wang, B.L. Sun, and J. Wang Lipase-sensitive polymeric triple-layered nanogel for "on-demand" drug delivery J. Am. Chem. Soc. 134 2012 4355 4362
148. K. Wayakanon, M.H. Thornhill, C.W. Douglas, A.L. Lewis, N.J. Warren, A. Pinnock, S.P. Armes, G. Battaglia, and C. Murdoch Polymersome-mediated intracellular delivery of antibiotics to treat Porphyromonas gingivalis-infected oral epithelial cells FASEB J. 27 2013 4455 4465
149. S.C. Abeylath, E. Turos, S. Dickey, and D.V. Lim Glyconanobiotics: novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis Bioorg. Med. Chem. 16 2008 2412 2418 (Pubitemid 351403660)
150. L. Heifets Microbiological aspects of rifapentine Drugs Today 35 1999 7 15 (Pubitemid 30010070)
151. A.S. Kaprelyants, J.C. Gottschal, and D.B. Kell Dormancy in non-sporulating bacteria FEMS Microbiol. Rev. 10 1993 271 285
152. M.B. Carlier, B. Scorneaux, A. Zenebergh, J.F. Desnottes, and P.M. Tulkens Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages J. Antimicrob. Chemother. 26 Suppl. B 1990 27 39 (Pubitemid 20382077)
153. R.H. Muller, K. Mader, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177 (Pubitemid 30326695)
154. M. Rawat, D. Singh, and S. Saraf Nanocarriers: promising vehicle for bioactive drugs Biol. Pharm. Bull. 29 2006 1790 1798 (Pubitemid 44338396)
155. P. Kolhe, E. Misra, R.M. Kannan, S. Kannan, and M. Lieh-Lai Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers Int. J. Pharm. 259 2003 143 160 (Pubitemid 36638561)
156. P. Deol, and G.K. Khuller Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice Biochim. Biophys. Acta 1334 1997 161 172 (Pubitemid 27117518)
157. Z. Drulis-Kawa, and A. Dorotkiewicz-Jach Liposomes as delivery systems for antimicrobial drug Int. J. Pharm. 387 2010 187 198
158. P. Couvreur, B. Stella, L.H. Reddy, H. Hillaireau, C. Dubernet, D. Desmaele, S. Lepetre-Mouelhi, F. Rocco, N. Dereuddre-Bosquet, P. Clayette, V. Rosilio, V. Marsaud, J.M. Renoir, and L. Cattel Squalenoyl nanomedicines as potential therapeutics Nano Lett. 6 2006 2544 2548 (Pubitemid 46076946)
159. N. Semiramoth, C. Di Meo, F. Zouhiri, F. Said-Hassane, S. Valetti, R. Gorges, V. Nicolas, J.H. Poupaert, S. Chollet-Martin, D. Desmaele, R. Gref, and P. Couvreur Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections ACS Nano 6 2012 3820 3831